Annual Working Capital
$358.65 M
+$224.38 M+167.10%
31 December 2023
Summary:
Phathom Pharmaceuticals annual working capital is currently $358.65 million, with the most recent change of +$224.38 million (+167.10%) on 31 December 2023. During the last 3 years, it has risen by +$191.05 million (+113.99%). PHAT annual working capital is now at all-time high.PHAT Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$308.53 M
+$50.75 M+19.69%
30 September 2024
Summary:
Phathom Pharmaceuticals quarterly working capital is currently $308.53 million, with the most recent change of +$50.75 million (+19.69%) on 30 September 2024. Over the past year, it has dropped by -$50.12 million (-13.97%). PHAT quarterly working capital is now -13.97% below its all-time high of $358.65 million, reached on 31 December 2023.PHAT Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAT Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -14.0% |
| 3 y3 years | +114.0% | +84.1% |
| 5 y5 years | +42.4% | +22.5% |
PHAT Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +167.1% | -14.0% | +146.0% |
| 5 y | 5 years | at high | +167.1% | -14.0% | +146.0% |
| alltime | all time | at high | >+9999.0% | -14.0% | +337.6% |
Phathom Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $308.53 M(+19.7%) |
| June 2024 | - | $257.78 M(-13.2%) |
| Mar 2024 | - | $296.86 M(-17.2%) |
| Dec 2023 | $358.65 M(+167.1%) | $358.65 M(+76.9%) |
| Sept 2023 | - | $202.75 M(-14.2%) |
| June 2023 | - | $236.17 M(+88.3%) |
| Mar 2023 | - | $125.40 M(-6.6%) |
| Dec 2022 | $134.28 M(-19.9%) | $134.28 M(-23.2%) |
| Sept 2022 | - | $174.93 M(-7.0%) |
| June 2022 | - | $188.18 M(+40.1%) |
| Mar 2022 | - | $134.35 M(-19.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $167.60 M(-28.9%) | $167.60 M(-15.1%) |
| Sept 2021 | - | $197.50 M(+15.0%) |
| June 2021 | - | $171.73 M(-15.0%) |
| Mar 2021 | - | $201.97 M(-14.4%) |
| Dec 2020 | $235.84 M(-6.4%) | $235.84 M(+18.2%) |
| Sept 2020 | - | $199.49 M(-15.3%) |
| June 2020 | - | $235.42 M(-8.5%) |
| Mar 2020 | - | $257.25 M(+2.1%) |
| Dec 2019 | $251.85 M(<-9900.0%) | $251.85 M(-294.0%) |
| Sept 2019 | - | -$129.84 M(+115.6%) |
| June 2019 | - | -$60.21 M(+4582.0%) |
| Dec 2018 | -$1.29 M | -$1.29 M |
FAQ
- What is Phathom Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Phathom Pharmaceuticals?
- What is Phathom Pharmaceuticals quarterly working capital year-on-year change?
What is Phathom Pharmaceuticals annual working capital?
The current annual working capital of PHAT is $358.65 M
What is the all time high annual working capital for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high annual working capital is $358.65 M
What is Phathom Pharmaceuticals quarterly working capital?
The current quarterly working capital of PHAT is $308.53 M
What is the all time high quarterly working capital for Phathom Pharmaceuticals?
Phathom Pharmaceuticals all-time high quarterly working capital is $358.65 M
What is Phathom Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, PHAT quarterly working capital has changed by -$50.12 M (-13.97%)